º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Economic Development

Government confirms Liverpool City Region as £320m investment zone

A further six investment zones are to be announced in England

An investment zone was first proposed for the Liverpool City Region in March(Image: Getty Images)

The Liverpool City Region has been confirmed as a £320m investment zone by the government.

The zone will be the second in England and is expected to create 4,000 jobs across Liverpool, Runcorn, St. Helens, Maghull and Prescot over the next five years.

An initial £10m investment will be made by US pharmaceutical manufacturer TriRx, to enhance its capabilities to manufacture monoclonal antibodies, a type of immunotherapy that work by blocking certain diseases from affecting healthy cells and are used to treat numerous types of diseases including cancers, arthritis and skin conditions.

READ MORE: Click here to sign up to the BusinessLive North West newsletter

The investment zone is being backed by £80m in government funding.

Levelling up minister Lee Rowley said: "Investment zones will drive growth across the º£½ÇÊÓÆµ. For Liverpool that means over £300m of private investment and 4,000 new, well-paid jobs – all building on the city’s world leading reputation in medical science.

"The health and life sciences sector already contributes an estimated £290 million to the Liverpool City Region’s economy every year. Building on this strength, the Liverpool City Region’s Investment Zone includes the University of Liverpool and is part of the government’s vision to drive growth in the sectors of the future including advanced manufacturing, green industries, digital and technology."

You are viewing an Accelerated Mobile Page.

This embedded content is not currently supported.

See it here

Mark Proctor, AstraZeneca site lead for Speke, added: "AstraZeneca welcomes the establishment of the Liverpool City Region Investment Zone focussed on life sciences, which has the potential to attract more businesses to the region’s already thriving medicine development and manufacturing cluster.